Kristopher R. Bosse

3.4k total citations
31 papers, 699 citations indexed

About

Kristopher R. Bosse is a scholar working on Neurology, Oncology and Molecular Biology. According to data from OpenAlex, Kristopher R. Bosse has authored 31 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 14 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Kristopher R. Bosse's work include Neuroblastoma Research and Treatments (21 papers), CAR-T cell therapy research (10 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Kristopher R. Bosse is often cited by papers focused on Neuroblastoma Research and Treatments (21 papers), CAR-T cell therapy research (10 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Kristopher R. Bosse collaborates with scholars based in United States, Canada and Italy. Kristopher R. Bosse's co-authors include John M. Maris, Sharon J. Diskin, Mike R. Russell, Michael P. Randall, Yaël P. Mossé, Kristina A. Cole, Marci Laudenslager, Jonathan H. Huggins, Edward F. Attiyeh and Rachel Sennett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Kristopher R. Bosse

27 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristopher R. Bosse United States 12 398 390 255 229 72 31 699
Nurten Yigit Belgium 15 343 0.9× 577 1.5× 264 1.0× 282 1.2× 100 1.4× 29 864
Kristina Ruuth Sweden 13 387 1.0× 392 1.0× 223 0.9× 170 0.7× 32 0.4× 23 694
Stacey M. Frumm United States 7 268 0.7× 588 1.5× 126 0.5× 123 0.5× 44 0.6× 12 724
Collin Van Ryn United States 10 534 1.3× 279 0.7× 172 0.7× 202 0.9× 44 0.6× 20 640
Shenghao Jin United States 11 70 0.2× 494 1.3× 176 0.7× 134 0.6× 33 0.5× 21 722
Buddha Gurung United States 11 107 0.3× 560 1.4× 366 1.4× 57 0.2× 88 1.2× 19 875
James N. Gerson United States 10 374 0.9× 236 0.6× 123 0.5× 98 0.4× 86 1.2× 16 636
Ludivine Le Dret France 8 211 0.5× 285 0.7× 90 0.4× 116 0.5× 18 0.3× 13 611
David Eaves United States 8 307 0.8× 191 0.5× 94 0.4× 35 0.2× 55 0.8× 9 539
Weifen Zeng United States 9 72 0.2× 173 0.4× 131 0.5× 115 0.5× 33 0.5× 12 416

Countries citing papers authored by Kristopher R. Bosse

Since Specialization
Citations

This map shows the geographic impact of Kristopher R. Bosse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristopher R. Bosse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristopher R. Bosse more than expected).

Fields of papers citing papers by Kristopher R. Bosse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristopher R. Bosse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristopher R. Bosse. The network helps show where Kristopher R. Bosse may publish in the future.

Co-authorship network of co-authors of Kristopher R. Bosse

This figure shows the co-authorship network connecting the top 25 collaborators of Kristopher R. Bosse. A scholar is included among the top collaborators of Kristopher R. Bosse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristopher R. Bosse. Kristopher R. Bosse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roth, Sydney L., Whitney L. Gladney, David Groff, et al.. (2025). D3-GPC2–Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer. Clinical Cancer Research. 31(24). 5276–5293.
2.
Roth, Sydney L., Minu Samanta, Guillem Pascual‐Pasto, et al.. (2025). Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cells. Molecular Therapy. 33(9). 4552–4569. 3 indexed citations
3.
Pascual‐Pasto, Guillem, Fatemeh Alikarami‬, Daniel Martínez, et al.. (2024). Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells. Clinical Cancer Research. 30(16). 3578–3591. 4 indexed citations
4.
Spear, Timothy T., David Groff, Kristopher R. Bosse, et al.. (2024). Abstract 5121: Next-generation immunocompetent and humanized neuroblastoma murine models for the discovery and validation of novel immunotherapies. Cancer Research. 84(6_Supplement). 5121–5121. 1 indexed citations
5.
Shraim, Rawan, Karina L. Conkrite, Amber K. Weiner, et al.. (2024). Abstract 1090: GPC2 directed CAR T cells are efficacious against fusion-positive and fusion-negative rhabdomyosarcomas. Cancer Research. 84(6_Supplement). 1090–1090.
6.
Randall, Michael P., Zalman Vaksman, Minu Samanta, et al.. (2023). BARD1germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma. JNCI Journal of the National Cancer Institute. 116(1). 138–148. 10 indexed citations
7.
Foster, Jessica, Jo Lynne Rokita, Komal S. Rathi, et al.. (2022). Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors. Journal for ImmunoTherapy of Cancer. 10(9). e004450–e004450. 30 indexed citations
8.
Pascual‐Pasto, Guillem, Rawan Shraim, Amy K. Erbe, et al.. (2022). GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies. Journal for ImmunoTherapy of Cancer. 10(12). e004704–e004704. 19 indexed citations
9.
Wolpaw, Adam J., Patricia Brafford, Guillem Pascual‐Pasto, et al.. (2022). Epigenetic state determines inflammatory sensing in neuroblastoma. Proceedings of the National Academy of Sciences. 119(6). 28 indexed citations
10.
Lane, Maria, et al.. (2021). Antibody–Drug Conjugate Efficacy in Neuroblastoma: Role of Payload, Resistance Mechanisms, Target Density, and Antibody Internalization. Molecular Cancer Therapeutics. 20(11). 2228–2239. 14 indexed citations
11.
Raman, Swetha, Maria Lane, Doncho V. Zhelev, et al.. (2021). A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope. Cell Reports Medicine. 2(7). 100344–100344. 21 indexed citations
12.
Foster, Jessica, Phillip B. Storm, David M. Barrett, et al.. (2021). IMMU-16. TARGETING GLYPICAN 2 (GPC2) ON PEDIATRIC MALIGNANT BRAIN TUMORS WITH MRNA CAR T CELLS. Neuro-Oncology. 23(Supplement_1). i30–i30. 1 indexed citations
13.
Cox, Julie, Melanie Weingart, Komal S. Rathi, et al.. (2020). LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase. Neoplasia. 22(6). 231–241. 19 indexed citations
14.
Sussman, Robyn T., Jo Lynne Rokita, Pichai Raman, et al.. (2020). CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma. Frontiers in Oncology. 10. 302–302. 11 indexed citations
15.
Bosse, Kristopher R., Maria Lane, John W. Wick, et al.. (2019). Abstract 3105: Serial profiling of ctDNA identifies clinically actionable genomic evolution in high-risk neuroblastoma. Cancer Research. 79(13_Supplement). 3105–3105. 1 indexed citations
16.
Diskin, Sharon J., Mario Capasso, Maura Diamond, et al.. (2014). Rare Variants in TP53 and Susceptibility to Neuroblastoma. JNCI Journal of the National Cancer Institute. 106(4). dju047–dju047. 86 indexed citations
17.
Bosse, Kristopher R., Aseem R. Shukla, Bruce Pawel, et al.. (2014). Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion. Cancer Genetics. 207(9). 415–419. 12 indexed citations
18.
Bosse, Kristopher R., et al.. (2013). A 7-Year-Old Boy with Abdominal Pain, Fever, and Rash. Pediatric Annals. 42(7). 275–277. 2 indexed citations
19.
Bosse, Kristopher R., et al.. (2013). Acute Renal Injury in a 14-year-old With HIV/AIDS and Tuberculosis. The Pediatric Infectious Disease Journal. 32(9). e380–e380.
20.
Bosse, Kristopher R.. (1971). Report on clinical experience with fluocinonide cream.. PubMed. 52(67). 57–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nurten Yigit Breakdown of academic impact, for papers by Kristina Ruuth Breakdown of academic impact, for papers by Stacey M. Frumm Breakdown of academic impact, for papers by Collin Van Ryn Breakdown of academic impact, for papers by Shenghao Jin Breakdown of academic impact, for papers by Buddha Gurung Breakdown of academic impact, for papers by James N. Gerson Breakdown of academic impact, for papers by Ludivine Le Dret Breakdown of academic impact, for papers by David Eaves Breakdown of academic impact, for papers by Weifen Zeng
Rankless by CCL
2026